Podcast

Diabetes Health: Bone May Have a Role in Blood Sugar Control

A new study in Cell shows that the human skeleton plays a key role in adjusting blood sugar.

A new study in Cell shows that the human skeleton plays a key role in adjusting blood sugar.

Click here to access this resource.

Related Videos
Advocating for Race-Neutral Approach to Pulmonary Function Testing with Meredith McCormack, MD, and Loretta Que, MD
Skin of Color Savvy: The Art and Science of Treating Patients of Color
Looking at This Year in Pulmonology: A Lungcast 2024 Recap
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Related Content
FDA black and white logo | Credit: US Food and Drug Administration
January 28th 2025

FDA Approves Semaglutide (Ozempic) for Type 2 Diabetes, Chronic Kidney Disease

Abigail Brooks, MA
Ep 16: A Look at Qlosi for Presbyopia with Elad Kedar, MBA| Image Credit: HCPLive
January 28th 2025

New Insight: A Look at Qlosi for Presbyopia with Elad Kedar, MBA

Veeral Sheth, MD, MBA, FASRS, FACS Connor Iapoce
Thyroid Cancer Diagnoses Rise in First Year of GLP-1 RA Use | Image Credit: University of Maryland
January 24th 2025

Thyroid Cancer Diagnoses Rise in First Year of GLP-1 RA Use

Connor Iapoce
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Therapeutics| Image Credit: HCPLive
January 23rd 2025

Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Therapeutics

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Semaglutide 7.2 mg Exhibits 20.7% Weight Loss in Phase 3b STEP UP Trial | Image Credit: Novo Nordisk
January 17th 2025

Semaglutide 7.2 mg Displays 20.7% Weight Loss in Phase 3b STEP UP Trial

Connor Iapoce
HHS Targets 15 Drugs for Medicare Part D Negotiations, Including Semaglutide | Image Credit: HHS
January 17th 2025

HHS Targets 15 Drugs for Medicare Part D Negotiations, Including Semaglutide

Connor Iapoce
© 2025 MJH Life Sciences

All rights reserved.